Economic evaluations of vaccines against respiratory infections in adults in Southeast Asia: A systematic review
- PMID: 40665593
- PMCID: PMC12269661
- DOI: 10.1080/21645515.2025.2528409
Economic evaluations of vaccines against respiratory infections in adults in Southeast Asia: A systematic review
Abstract
Respiratory infections significantly impact adult health in Southeast Asia, yet vaccine coverage remains low. This systematic review evaluated the economic evaluations of vaccines targeting respiratory infections in the region. A comprehensive search was conducted across several databases, including MEDLINE/PubMed, EMBASE, NHSEED, CINAHL, EconLit, Web of Science, Scopus, and Cochrane Library, up to April 24, 2024. Nineteen eligible studies were identified, focusing primarily on influenza (8 studies) and COVID-19 vaccines (7 studies), with fewer studies on pneumococcal (2 studies), varicella (1 study), and pertussis (1 study) vaccines. Overall, influenza, COVID-19 (boosters), and pneumococcal vaccines were found to be cost-effective or highly cost-effective compared to no-vaccine or no-booster scenarios. The only study on maternal pertussis vaccination found it not to be cost-effective. The most common parameters considered in sensitivity analyses were vaccine efficacy and discount rates. This review highlights the economic evaluations of influenza, COVID-19, and pneumococcal vaccines in Southeast Asia, providing essential evidence to guide vaccine policy. Future studies should address limitations in model selection, incorporate herd immunity, ensure the model validation (i.e. validity of cost and benefit measurements), and explore the cost-effectiveness of other vaccines across the region.
Keywords: Southeast Asia; Systematic review; adults; economic evaluation; respiratory infection; vaccine.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures
References
-
- Bender RG, Sirota SB, Swetschinski LR, Dominguez RMV, Novotney A, Wool EE, Ikuta KS, Vongpradith A, Rogowski ELB, Doxey M, et al. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the global burden of disease study 2021. Lancet Infect Dis. 2024;24(9):974–23. doi: 10.1016/S1473-3099(24)00176-2. - DOI - PMC - PubMed
-
- Worldometer . Reported cases and deaths by country or territory. 2024. [accessed 2024 Oct 4]. https://www.worldometers.info/coronavirus/.
-
- WHO . COVID-19 remains a persistent public health threat. 2024. [accessed 2024 Oct 4]. https://www.emro.who.int/media/news/covid-19-remains-a-persistent-public....
-
- WHO . Global immunization policy and guidance. [accessed 2024 Aug 28]. https://www.who.int/teams/immunization-vaccines-and-biologicals/policies.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous